Twelve-week, long-term extension study evaluating the optimal dose of danazol for diabetic macular oedema.
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2015
At a glance
- Drugs Danazol (Primary)
- Indications Diabetic macular oedema
- Focus Registrational; Therapeutic Use
- Sponsors Ampio Pharmaceuticals
- 22 Jun 2015 Results published in an Ampio Pharmaceuticals media release.
- 22 Nov 2013 New trial record